中华危重病急救医学
中華危重病急救醫學
중화위중병급구의학
Chinese Critical Care Medicine
2015年
2期
81-85
,共5页
脂多糖%内皮细胞%普通肝素%Toll样受体%粒细胞集落刺激因子
脂多糖%內皮細胞%普通肝素%Toll樣受體%粒細胞集落刺激因子
지다당%내피세포%보통간소%Toll양수체%립세포집락자격인자
Lipopolysaccharide%Endothelial cell%Unfractionated heparin%Toll-like receptor%Granulocyte colony-stimulating factor
目的:观察肝素对脂多糖(LPS)刺激人内皮细胞粒细胞集落刺激因子(G-CSF)水平的影响,并探讨Toll样受体4(TLR4)在其过程中的可能作用。方法体外培养人肺微血管内皮细胞(HPMEC),取传代培养至第3~5代细胞用于实验。实验1:将细胞分为对照组、LPS刺激组(LPS 10μg/mL)、LPS+0.1 U/mL肝素组和LPS+1 U/mL肝素组4组,肝素作用组于LPS刺激前15 min加入相应剂量普通肝素,对照组加入与LPS等量的磷酸盐缓冲液(PBS);于LPS刺激24 h后收集细胞上清,采用酶联免疫吸附试验(ELISA)测定白细胞介素-6(IL-6)、 G-CSF水平,以明确肝素对HPMEC的作用。实验2:另取细胞,分别于加入PBS或LPS前4 h加入5μg/mL球形红细菌LPS(LPS-RS,一种TLR4拮抗剂);于LPS刺激24 h后收集细胞上清,测定IL-6、 G-CSF水平,以明确TLR4在LPS诱导HPMEC损伤中的作用。实验3:另取细胞,分为对照组、LPS刺激组、LPS+0.1 U/mL肝素组和LPS+1 U/mL肝素组,处理方法同实验1;于LPS刺激1 h后收集细胞,采用蛋白质免疫印迹试验(Western Blot)测定TLR4蛋白表达,以明确肝素对TLR4的作用。结果①与对照组比较,LPS刺激组IL-6及G-CSF水平明显增高〔IL-6(ng/L):655.9±58.3比75.5±18.2,G-CSF(ng/L):388.7±36.2比35.3±12.6,均P<0.05〕;与LPS刺激组比较,0.1 U/mL和1 U/mL肝素预处理均可明显降低IL-6及G-CSF水平〔IL-6(ng/L):518.2±64.6、489.1±75.6比655.9±58.3,G-CSF(ng/L):298.8±41.0、273.4±33.2比388.7±36.2,均P<0.05〕,两个肝素组间无明显差异,但以1 U/mL肝素作用较明显。② LPS-RS可明显抑制LPS诱导的IL-6、 G-CSF水平增高〔IL-6(ng/L):139.1±37.6比655.9±58.3, G-CSF(ng/L):73.7±19.7比388.7±36.2,均P<0.05〕;而单独应用LPS-RS对细胞因子无明显影响〔IL-6(ng/L):118.2±42.1比75.5±18.2,G-CSF (ng/L):48.4±26.8比35.3±12.6,均P>0.05〕。③ LPS刺激1 h后TLR4蛋白表达(灰度值)明显高于对照组(0.87±0.23比0.36±0.12,P<0.05);0.1 U/mL和1 U/mL肝素预处理均可明显抑制LPS诱导的TLR4蛋白表达(0.68±0.18、0.62±0.26比0.87±0.23,均P<0.05)。结论 LPS刺激下HPMEC中IL-6、G-CSF表达增加,肝素可能通过调节TLR4降低其表达水平,从而发挥细胞保护作用。
目的:觀察肝素對脂多糖(LPS)刺激人內皮細胞粒細胞集落刺激因子(G-CSF)水平的影響,併探討Toll樣受體4(TLR4)在其過程中的可能作用。方法體外培養人肺微血管內皮細胞(HPMEC),取傳代培養至第3~5代細胞用于實驗。實驗1:將細胞分為對照組、LPS刺激組(LPS 10μg/mL)、LPS+0.1 U/mL肝素組和LPS+1 U/mL肝素組4組,肝素作用組于LPS刺激前15 min加入相應劑量普通肝素,對照組加入與LPS等量的燐痠鹽緩遲液(PBS);于LPS刺激24 h後收集細胞上清,採用酶聯免疫吸附試驗(ELISA)測定白細胞介素-6(IL-6)、 G-CSF水平,以明確肝素對HPMEC的作用。實驗2:另取細胞,分彆于加入PBS或LPS前4 h加入5μg/mL毬形紅細菌LPS(LPS-RS,一種TLR4拮抗劑);于LPS刺激24 h後收集細胞上清,測定IL-6、 G-CSF水平,以明確TLR4在LPS誘導HPMEC損傷中的作用。實驗3:另取細胞,分為對照組、LPS刺激組、LPS+0.1 U/mL肝素組和LPS+1 U/mL肝素組,處理方法同實驗1;于LPS刺激1 h後收集細胞,採用蛋白質免疫印跡試驗(Western Blot)測定TLR4蛋白錶達,以明確肝素對TLR4的作用。結果①與對照組比較,LPS刺激組IL-6及G-CSF水平明顯增高〔IL-6(ng/L):655.9±58.3比75.5±18.2,G-CSF(ng/L):388.7±36.2比35.3±12.6,均P<0.05〕;與LPS刺激組比較,0.1 U/mL和1 U/mL肝素預處理均可明顯降低IL-6及G-CSF水平〔IL-6(ng/L):518.2±64.6、489.1±75.6比655.9±58.3,G-CSF(ng/L):298.8±41.0、273.4±33.2比388.7±36.2,均P<0.05〕,兩箇肝素組間無明顯差異,但以1 U/mL肝素作用較明顯。② LPS-RS可明顯抑製LPS誘導的IL-6、 G-CSF水平增高〔IL-6(ng/L):139.1±37.6比655.9±58.3, G-CSF(ng/L):73.7±19.7比388.7±36.2,均P<0.05〕;而單獨應用LPS-RS對細胞因子無明顯影響〔IL-6(ng/L):118.2±42.1比75.5±18.2,G-CSF (ng/L):48.4±26.8比35.3±12.6,均P>0.05〕。③ LPS刺激1 h後TLR4蛋白錶達(灰度值)明顯高于對照組(0.87±0.23比0.36±0.12,P<0.05);0.1 U/mL和1 U/mL肝素預處理均可明顯抑製LPS誘導的TLR4蛋白錶達(0.68±0.18、0.62±0.26比0.87±0.23,均P<0.05)。結論 LPS刺激下HPMEC中IL-6、G-CSF錶達增加,肝素可能通過調節TLR4降低其錶達水平,從而髮揮細胞保護作用。
목적:관찰간소대지다당(LPS)자격인내피세포립세포집락자격인자(G-CSF)수평적영향,병탐토Toll양수체4(TLR4)재기과정중적가능작용。방법체외배양인폐미혈관내피세포(HPMEC),취전대배양지제3~5대세포용우실험。실험1:장세포분위대조조、LPS자격조(LPS 10μg/mL)、LPS+0.1 U/mL간소조화LPS+1 U/mL간소조4조,간소작용조우LPS자격전15 min가입상응제량보통간소,대조조가입여LPS등량적린산염완충액(PBS);우LPS자격24 h후수집세포상청,채용매련면역흡부시험(ELISA)측정백세포개소-6(IL-6)、 G-CSF수평,이명학간소대HPMEC적작용。실험2:령취세포,분별우가입PBS혹LPS전4 h가입5μg/mL구형홍세균LPS(LPS-RS,일충TLR4길항제);우LPS자격24 h후수집세포상청,측정IL-6、 G-CSF수평,이명학TLR4재LPS유도HPMEC손상중적작용。실험3:령취세포,분위대조조、LPS자격조、LPS+0.1 U/mL간소조화LPS+1 U/mL간소조,처리방법동실험1;우LPS자격1 h후수집세포,채용단백질면역인적시험(Western Blot)측정TLR4단백표체,이명학간소대TLR4적작용。결과①여대조조비교,LPS자격조IL-6급G-CSF수평명현증고〔IL-6(ng/L):655.9±58.3비75.5±18.2,G-CSF(ng/L):388.7±36.2비35.3±12.6,균P<0.05〕;여LPS자격조비교,0.1 U/mL화1 U/mL간소예처리균가명현강저IL-6급G-CSF수평〔IL-6(ng/L):518.2±64.6、489.1±75.6비655.9±58.3,G-CSF(ng/L):298.8±41.0、273.4±33.2비388.7±36.2,균P<0.05〕,량개간소조간무명현차이,단이1 U/mL간소작용교명현。② LPS-RS가명현억제LPS유도적IL-6、 G-CSF수평증고〔IL-6(ng/L):139.1±37.6비655.9±58.3, G-CSF(ng/L):73.7±19.7비388.7±36.2,균P<0.05〕;이단독응용LPS-RS대세포인자무명현영향〔IL-6(ng/L):118.2±42.1비75.5±18.2,G-CSF (ng/L):48.4±26.8비35.3±12.6,균P>0.05〕。③ LPS자격1 h후TLR4단백표체(회도치)명현고우대조조(0.87±0.23비0.36±0.12,P<0.05);0.1 U/mL화1 U/mL간소예처리균가명현억제LPS유도적TLR4단백표체(0.68±0.18、0.62±0.26비0.87±0.23,균P<0.05)。결론 LPS자격하HPMEC중IL-6、G-CSF표체증가,간소가능통과조절TLR4강저기표체수평,종이발휘세포보호작용。
ObjectiveTo determine the effect of unfractionated heparin (UFH) on lipopolysaccharide (LPS)-induced expression of granulocyte colony-stimulating factor (G-CSF), and the role of Toll-like receptor 4 (TLR4) signaling pathway in this process.Methods Human pulmonary microvascular endothelial cells (HPMECs) were cultured in vitro, and the cells between passages 3 and 5 were used in the experiments. ExperimentⅠ: the cells were divided into four groups as follows: control group, LPS stimulation group (LPS 10μg/mL), LPS+ 0.1 U/mL UFH group, and LPS+ 1 U/mL UFH group. HPMECs in UFH groups were treated with 0.1 U/mL or 1 U/mL UFH 15 minutes before LPS stimulation, and HPMECs in control group were treated with an equal volume of phosphate-buffered saline (PBS) instead. The concentrations of interleukin-6 (IL-6) and G-CSF in cell culture supernatants were determined by enzyme linked immunosorbent assay (ELISA) 24 hours after LPS challenge to detect the effect of UFH on HPMECs. ExperimentⅡ: HPMECs were treated with 5μg/mL of rhodobacter sphaeroides LPS (LPS-RS, antagonist for TLR4) 4 hours before the addition of PBS or LPS. The concentrations of IL-6 and G-CSF in cell culture supernatants were determined 24 hours after LPS stimulation to detect the effect of TLR4 on LPS-induced HPMEC injury. ExperimentⅢ: HPMECs were divided into four groups as before: control group, LPS stimulation group, LPS+ 0.1 U/mL UFH group, LPS+ 1 U/mL UFH group. Treatments to cells were the same as experimentⅠ. The protein expression of TLR4 in HPMECs was determined by Western Blot 1 hour after LPS stimulation to detect the effect of UFH on TLR4.Results① Compared with control group, the levels of IL-6 and G-CSF in LPS stimulation group were increased [IL-6 (ng/L): 655.9±58.3 vs. 75.5±18.2, G-CSF (ng/L): 388.7±36.2 vs. 35.3±12.6, both P< 0.05]. Compared with those of LPS stimulation group, in LPS+ 0.1 U/mL UFH group and LPS+ 1 U/mL UFH group, the levels of IL-6 and G-CSF were significantly decreased [IL-6 (ng/L): 518.2±64.6, 489.1±75.6 vs. 655.9±58.3, G-CSF (ng/L): 298.8±41.0, 273.4±33.2 vs. 388.7±36.2, allP< 0.05]. The results indicated that 1 U/mL UFH had better results, though there was no statistical significance between the results of two UFH groups.② LPS-induced up-regulation of IL-6 and G-CSF levels was prevented by LPS-RS [IL-6 (ng/L): 139.1±37.6 vs. 655.9±58.3, G-CSF (ng/L): 73.7±19.7 vs. 388.7±36.2, bothP< 0.05]. LPS-RS alone had no effect on cytokines [IL-6 (ng/L):118.2±42.1 vs. 75.5±18.2, G-CSF (ng/L): 48.4±26.8 vs. 35.3±12.6, bothP> 0.05].③ Compared with control group, the protein expression of TLR4 (grey value) in LPS stimulation group was significantly upregulated after 1 hour (0.87±0.23 vs. 0.36±0.12,P< 0.05). UFH with 0.1 U/mL and 1 U/mL lowered TLR-4 protein expression induced by LPS (0.68±0.18, 0.62±0.26 vs. 0.87±0.23, bothP< 0.05).ConclusionsThe expressions of IL-6 and G-CSF were increased obviously in LPS treated HPMECs. UFH might take its therapeutic effect through TLR4-dependent pathway.